Revogenex, Coronado Biosciences deal

Revogenex granted Coronado exclusive, U.S. rights to develop and commercialize IV tramadol. Coronado will transfer the license to its newly formed subsidiary, Avenue Therapeutics Inc., which will focus on developing and commercializing products for use in the U.S. hospital market. ...